Renalytix Plc (AIM:RENX)
London · Delayed Price · Currency is GBP · Price in GBX 1.860
-0.040 (-2.11%)
Jun 17, 2026, 3:34 PM GMT
Renalytix Market Cap
Renalytix has a market cap or net worth of 8.3 million as of June 17, 2026. Its market cap has decreased by -65.42% in one year.
Market Cap
8.30M
Enterprise Value
8.01M
Revenue
2.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.86
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 8.30M, a decrease of -87.14%. That is a compound annual growth rate of -23.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 8.30M | -67.80% |
| Dec 31, 2025 | 25.78M | -27.58% |
| Dec 31, 2024 | 35.60M | 129.87% |
| Dec 29, 2023 | 15.49M | -71.47% |
| Dec 30, 2022 | 54.30M | -87.89% |
| Dec 31, 2021 | 448.32M | 27.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 206.03B |
| GSK plc | 78.16B |
| Haleon | 29.53B |
| Smith & Nephew | 9.60B |
| RUA Life Sciences | 12.10M |
| Genflow Biosciences | 12.04M |
| Oxford BioDynamics | 8.20M |
| GENinCode | 7.15M |